AXQ Capital’s Sight Sciences SGHT Stock Holding History

AXQ Capital’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,226	Closed	-$89K	–	1234
2025 Q4	$89K	Buy	+11,226	New	+$71.7K	0.02%	667

Other funds holding SGHT

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

AXQ Capital's SGHT Position: Q1 2026 in Review

AXQ Capital sold out of Sight Sciences (SGHT) in Q1 2026, closing a stake of 11,226 shares — an estimated $89K sold.

AXQ Capital first reported a position in SGHT in Q4 2025 and held it in 1 quarter. The position peaked at $89K in Q4 2025. 114 funds tracked by Wall St. Rank hold SGHT as of Q1 2026.

AXQ Capital reported no remaining Sight Sciences position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 11,226 Sight Sciences shares in Q1 2026, an estimated $89K.
AXQ Capital first reported a position in Sight Sciences in Q4 2025 and held it in 1 quarter.
AXQ Capital's Sight Sciences position peaked at $89K in Q4 2025.
114 funds tracked by Wall St. Rank held Sight Sciences as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.